Fabrication of nanoadjuvant with poly-σ- caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity

Chandravilas Keshvan Prashant, Madhusudan Bhat, Sandeep Srivastava Kumar, Ankit Saxena, Manoj Kumar, Amar Singh, Mohammed Samim, Farhan Jalees Ahmad, Amit Kumar Dinda

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Purpose: The aim of the study was to load a model antigen, tetanus toxoid (TT), in poly-σ- caprolactone nanoparticles (PCL NPs) of two size ranges, ie, mean 61.2 nm (small) and 467.6 nm (large), and study its effect on macrophage polarization as well as antigen presentation in human monocyte-derived macrophages in vitro, along with humoral and cell-mediated immune (CMI) response generated in Swiss albino mice following immunization with the TT-loaded NPs. Materials and methods: PCL NPs were synthesized by solvent evaporation. The antigen- loaded PCL NPs were characterized for size, zeta potential, and protein-release kinetics. Swiss albino mice were immunized with the antigen-loaded PCL NPs. Flow cytometry was used to quantify interferon-γ- and interleukin-4-secreting cluster of differentiation (CD)4+ and CD8+ T cells in the spleen, and enzyme-linked immunosorbent assay was used to quantify anti-TT antibody levels in the serum of immunized mice. Results: Small PCL NPs generated an M1/M2 type polarization of human blood monocyte- derived macrophages and T helper (Th)1/Th2 polarization of autologous CD4+ T cells. Efficient CD8+ T-cell responses were also elicited. Large PCL NPs failed to cause any type of macrophage polarization. They did not elicit efficient CD8+ T-cell responses. Conclusion: TT-loaded small PCL NPs were able to generate persistent and strong CMI and humoral responses against TT 2 months after single injection in mice without booster dose. This biodegradable nanoadjuvant system may help to develop single-shot immunization for prolonged immunity without booster doses. The capability of enhanced CMI response may have high translational potential for immunization against intracellular infection.

Original languageEnglish (US)
Article number937
Pages (from-to)937-950
Number of pages14
JournalInternational Journal of Nanomedicine
Issue number1
StatePublished - Feb 12 2014
Externally publishedYes


  • Adjuvant
  • Antigen cross-presentation
  • Poly-σ-caprolactone nanoparticles
  • Tetanus toxoid
  • Vaccine


Dive into the research topics of 'Fabrication of nanoadjuvant with poly-σ- caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity'. Together they form a unique fingerprint.

Cite this